Company intelligence / Profile preview

Minskintercaps

Minsk, Belarus

Ownership: Private
Employees: ~330
Development stage: Other

Overview

Minskintercaps manufactures over 70 pharmaceuticals and supplements (mainly generics of imported drugs) in hard and soft gelatin capsules. Their products meet European and Belarusian GMP quality standards, and the company is a national industry leader focused on cardiovascular, neurological, hepatoprotective, cold/flu, and vitamin therapies.

Therapeutic areas: Metabolic DisordersOphthalmologyMen's HealthInfectious DiseasesGastroenterologyCardiovascularNeurologyWomen's Health
Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

6 assets

AnGriMax

Unknown

5 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Minskintercaps.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Minskintercaps.

Explore the full profile